Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYREN Ltd.CYRN · Entity 121490 | Director | September 22, 2022 | September 26, 2022 |
| DarioHealth Corp.DRIO · Entity 7024 | Director | September 24, 2026 | September 28, 2026 |
| Indaptus Therapeutics, Inc.INDP · Entity 6530 | Director | June 10, 2025 | June 11, 2025 |
| Intec Pharma Ltd.NTEC · Entity 146542 | Director | July 15, 2020 | July 17, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYREN Ltd.
Report date September 22, 2022 · Filed September 26, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 25,197 |
Reported balance
After 2022-09-22 transaction · row 1
1 source rowRow 1 · 2022-09-22 · Grant · Acquired 17,500 · Balance 25,197 F1: These shares were issued as a restricted stock unit grant to the Reporting Person by the issuer. The restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date of September 22, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were issued as a restricted stock unit grant to the Reporting Person by the issuer. The restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date of September 22, 2022.
DarioHealth Corp.
Report date September 24, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,965 |
Reported balance
After 2026-09-24 transaction · row 1
1 source rowRow 1 · 2026-09-24 · Grant · Acquired 28,000 · Balance 58,965 F1: The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period.
Indaptus Therapeutics, Inc.
Report date June 10, 2025 · Filed June 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.33 · Expires 2035-06-10 | Direct | 12,500 |
Reported balance
After 2025-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-10 · Grant · Acquired 12,500 · Balance 12,500 F1: The stock option vests and becomes exercisable on June 10, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vests and becomes exercisable on June 10, 2026.
Intec Pharma Ltd.
Report date July 15, 2020 · Filed July 17, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.31 · Expires 2027-07-15 | Direct | 40,000 |
Reported balance
After 2020-07-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-07-15 · Grant · Acquired 40,000 · Balance 40,000 F1: The stock option vests and becomes exercisable as to one-third of the total shares on July 15, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through July 15, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vests and becomes exercisable as to one-third of the total shares on July 15, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through July 15, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 28, 2026 20:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-111346 · tm2626098-5_4seq1.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,965 F1 · date: The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 16:06 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-089997 · tm2526001-4_4seq1.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,965 F1 · date: The restricted share award shall vest in two equal installments on the last day of each successive annual anniversary after the grant date over a two-year period. F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 16:05 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001641172-25-014692 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2035-06-10 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on June 10, 2026. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 16:15 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | Disposition to issuerStock Option (right to buy) · Derivative | 250 | $0.39 Strike: $355.20 | $97.50 |
DisclosureSEC source: 0001641172-25-003821 · ownership.xml · derivative · entry 4 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2025-06-28 F1 · price: The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 16:15 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | Disposition to issuerStock Option (right to buy) · Derivative | 281 | $0.39 Strike: $480.00 | $109.59 |
DisclosureSEC source: 0001641172-25-003821 · ownership.xml · derivative · entry 3 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 281 shares Expires 2026-05-22 F1 · price: The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 16:15 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | Disposition to issuerStock Option (right to buy) · Derivative | 250 | $0.39 Strike: $388.64 | $97.50 |
DisclosureSEC source: 0001641172-25-003821 · ownership.xml · derivative · entry 2 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2026-06-28 F1 · price: The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 16:15 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | Disposition to issuerStock Option (right to buy) · Derivative | 500 | $0.39 Strike: $24.60 | $195.00 |
DisclosureSEC source: 0001641172-25-003821 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2027-07-15 F1 · price: The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 17:00 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001493152-24-023152 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on June 6, 2025. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 16:20 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-032411 · tm248350-5_4seq1.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,290 F1 · date: The shares vest as follows: (i) 50% vest on the grant date and (ii) 50% vest in quarterly instalments on the last day of each calendar quarter commencing March 31, 2024 for a two year period. Read SEC document |
| May 25, 2023 Filed May 30, 2023 16:15 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001493152-23-019462 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-05-25 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on May 25, 2024. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 16:31 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | GrantStock Option (right to buy) · Derivative | 13,750 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001493152-22-027441 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2032-09-30 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on September 30, 2023. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 16:11 UTC | CYREN Ltd. CYRN · Entity 121490 | GrantOrdinary Shares | 17,500 | $1.18 | $20,650.00 |
DisclosureSEC source: 0001628280-22-025470 · wf-form4_166422307113339.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,197 F1 · shares: These shares were issued as a restricted stock unit grant to the Reporting Person by the issuer. The restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date of September 22, 2022. Read SEC document |
| May 18, 2022 Filed May 20, 2022 17:02 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-063451 · tm2216123-6_4seq1.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,290 F1 · shares: The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter. Read SEC document |
| August 04, 2021 Filed Aug 6, 2021 17:00 UTC | Indaptus Therapeutics, Inc. INDP · Entity 6530 | GrantStock Option (right to buy) · Derivative | 13,750 | $0.00 Strike: $8.87 | $0.00 |
DisclosureSEC source: 0001493152-21-018908 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2031-08-04 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on August 4, 2022. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 17:34 UTC | CYREN Ltd. CYRN · Entity 121490 | GrantOrdinary Shares | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-038430 · ownership.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,931 F1 · shares: These shares were issued as a restricted stock unit grant to the Reporting Person by the issuer under the issuer's 2016 Non-Employee Director Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on July 21, 2022. F2 · balance_after: Reflects a reduction of shares to correct an error in the number previously reported. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 16:08 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantRestricted Stock Grant | 20,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-006291 · tm213677-5_4seq1.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,290 F1 · date: The shares vest over three years as follows: 8.333% shall vest on March 31, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:22 UTC | CYREN Ltd. CYRN · Entity 121490 | GrantOrdinary Shares | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-000677 · ownership.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,931 F1 · shares: These shares were issued as a restricted stock unit grant to the Reporting Person by the issuer under the issuer's 2016 Non-Employee Director Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2022. Read SEC document |
| October 16, 2020 Filed Oct 20, 2020 16:09 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 1,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-116436 · tm2033754d5_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,143 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2020. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 16:08 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 2,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-085624 · tm2025176d4_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,771 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2020. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 16:33 UTC | Intec Pharma Ltd. NTEC · Entity 146542 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001213900-20-017810 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Ordinary Shares · 40,000 shares Expires 2027-07-15 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on July 15, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through July 15, 2023. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 16:08 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 2,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-044160 · tm2015091d9_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,393 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2020. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 16:15 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-021770 · tm207834-4_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,015 Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 16:07 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 2,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-008685 · tm206156d4_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,015 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2019. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 17:06 UTC | CYREN Ltd. CYRN · Entity 121490 | GrantOrdinary Shares | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-000551 · ownership.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,931 F1 · shares: These shares were issued as a restricted stock unit grant to the reporting person by the issuer under the issuer's 2016 Non-Employee Director Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 06, 2021. Read SEC document |
| December 23, 2019 Filed Dec 26, 2019 16:07 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 2,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-076121 · tm1927375-5_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,637 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2019 in the aggregate amount of $10,250. Read SEC document |
| July 09, 2019 Filed Jul 10, 2019 16:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 34,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-034301 · tv524964_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,158 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the first and second quarters of 2019 in the aggregate amount of $20,500. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 16:37 UTC | Intec Pharma Ltd. NTEC · Entity 146542 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001213900-19-011967 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2026-06-28 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on June 28, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through June 28, 2022. Read SEC document |
| April 29, 2019 Filed Apr 30, 2019 17:01 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 25,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-022462 · tv520234_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,992 Read SEC document |
| January 27, 2019 Filed Jan 29, 2019 16:03 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 10,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-003512 · tv511866_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,883 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2018 in the amount of $10,250. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 17:36 UTC | CYREN Ltd. CYRN · Entity 121490 | GrantOrdinary Shares | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-001187 · ownership.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,931 F1 · shares: These shares were issued as a restricted stock unit grant to the reporting person by the issuer under the issuer's 2016 Non-Employee Director Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 22, 2020. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 16:00 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.70 | $3,500.00 |
DisclosureSEC source: 0001144204-18-061225 · tv507651_form4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,633 Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 16:22 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 10,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-052749 · tv504216_form4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,633 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2018 in the amount of $10,250. Read SEC document |
| July 09, 2018 Filed Jul 10, 2018 16:07 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 7,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-037841 · tv498260_form4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,321 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2018 in the amount of $10,250. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 16:08 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 24,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-033548 · tv496165_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,282 Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 16:08 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 6,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-022376 · tv491864_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,929 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2018 in the amount of $10,250. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 16:14 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 6,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-001302 · tv482693_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,276 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2017 in the amount of $10,250. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 16:07 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 5,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-054096 · tv477608_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,745 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2017 in the amount of $10,250. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 16:08 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 4,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-036440 · v470580_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,224 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2017 in the amount of $10,250. Read SEC document |
| April 13, 2017 Filed Apr 17, 2017 16:18 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 2,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-020713 · v464365_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,791 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2017 in the amount of $10,250. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 16:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 16,007 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001144204-17-005353 · v457878_4.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,007 Underlying: Common Stock · 16,007 shares Expires 2023-01-30 F1 · derivative.exercise_date: The option vests in twelve equal quarterly installments commencing on January 30, 2017. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 16:37 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 6,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-002208 · v456898_4.xml · nonDerivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,991 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter and fourth quarter of 2016 in the amount of $20,500. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.